Bloomage Biotechnology Overview
- Founded
- 2006
- Status
- Public
- Employees
- 2,082
- Stock Symbol
- 688363
- Investments
- 5
- Share Price
- $26.20
- (As of Wednesday Closing)
Bloomage Biotechnology General Information
Description
Bloomage BioTechnology Corp Ltd manufactures and sells a variety of chemicals and chemical-based products, typically made from hyaluronic acid sodium, or HA. The firm organizes itself into two segments based on product type. The HA raw materials segment, which generates the majority of revenue, sells HA and HA derivatives produced using bio-fermentation technology. The HA raw materials segment products are classified into three grades of HA: medicine grade, cosmetic grade, and food grade. The HA end products segment sells medical skin care products, bone products for intra-articular injection, and medical beauty devices. The majority of revenue comes from China.
Contact Information
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
SHG
Primary Office
- Floor 33, Tower D, Bloomage International Center
- 6A, Jianguomenwai Avenue
- Beijing, Chaoyang
- China
+86 010 0000 0000
Bloomage Biotechnology Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $26.20 | $26.73 | $20.14 - $48.65 | $12.6B | 480M | 3.46M | $0.23 |
Bloomage Biotechnology Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 |
|---|---|---|---|---|
| EV | 20,348,800 | 10,482,652 | 5,628,057 | |
| Revenue | 546,307 | 381,080 | 272,890 | 190,944 |
| EBITDA | 144,368 | 117,399 | 109,196 | 84,535 |
| Net Income | 111,512 | 93,483 | 84,752 | 64,073 |
| Total Assets | 1,012,872 | 875,039 | 710,562 | 301,062 |
| Total Debt | 43,090 | 3,685 | 0 | 5,815 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Bloomage Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Bloomage Biotechnology‘s full profile, request access.
Request a free trialBloomage Biotechnology Executive Team (6)
Bloomage Biotechnology Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00 0000000 | Bloomage Biotechnology | Chairman of Audit Committee & Board Member | 000 0000 |
| 0000 0000 | Bloomage Biotechnology | Board Member & Chairman of Nomination Committee and Member of Audit Committee | 000 0000 |
| 0000 000 | Bloomage Biotechnology | Chairman & Executive Director | 000 0000 |
Bloomage Biotechnology Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialBloomage Biotechnology Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Bloomage Biotechnology‘s full profile, request access.
Request a free trialBloomage Biotechnology Investments & Acquisitions (5)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 | 08-Jan-2017 | 000000000000000000 | 000.00 | Pharmaceuticals | |
| 000000000000 00000 | 22-Dec-2016 | 000000000 | Medical Supplies | ||
| 000000000 | 27-Jul-2015 | 00000 0000000 | Pharmaceuticals | ||
| 000000000000 00000 | 15-Jul-2015 | 000000000 00000000 | Medical Supplies | ||
| V Plus | 15-Jul-2015 | Corporate | 000.00 | Medical Supplies |
Bloomage Biotechnology Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 0000000000 | Pharmaceuticals | Saint-Ouen-l'Aumône, France | 0000 |